Abstract:The clinical application of technological progress in the identification of DNA alterations has always led to improvements of diagnostic yields in genetic medicine. At chromosome side, from cytogenetic techniques evaluating number and gross structural defects to genomic microarrays detecting cryptic copy number variants, and at molecular level, from Sanger method studying the nucleotide sequence of single genes to the high-throughput next-generation sequencing (NGS) technologies, resolution and sensitivity progressively increased expanding considerably the range of detectable DNA anomalies and alongside of Mendelian disorders with known genetic causes. However, particular genomic regions (i.e., repetitive and GC-rich sequences) are inefficiently analyzed by standard genetic tests, still relying on laborious, time-consuming and low-sensitive approaches (i.e., southern-blot for repeat expansion or long-PCR for genes with highly homologous pseudogenes), accounting for at least part of the patients with undiagnosed genetic disorders. Third generation sequencing, generating long reads with improved mappability, is more suitable for the detection of structural alterations and defects in hardly accessible genomic regions. Although recently implemented and not yet clinically available, long read sequencing (LRS) technologies have already shown their potential in genetic medicine research that might greatly impact on diagnostic yield and reporting times, through their translation to clinical settings. The main investigated LRS application concerns the identification of structural variants and repeat expansions, probably because techniques for their detection have not evolved as rapidly as those dedicated to single nucleotide variants (SNV) identification: gold standard analyses are karyotyping and microarrays for balanced and unbalanced chromosome rearrangements, respectively, and southern blot and repeat-primed PCR for the amplification and sizing of expanded alleles, impaired by limited resolution and sensitivity that have not been significantly improved by the advent of NGS. Nevertheless, more recently, with the increased accuracy provided by the latest product releases, LRS has been tested also for SNV detection, especially in genes with highly homologous pseudogenes and for haplotype reconstruction to assess the parental origin of alleles with de novo pathogenic variants. We provide a review of relevant recent scientific papers exploring LRS potential in the diagnosis of genetic diseases and its potential future applications in routine genetic testing.

Next-Generation Sequencing and Emerging Technologies*

The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice

Next-Generation Sequencing Technology: Current Trends and Advancements

Next-generation sequencing technologies: breaking the sound barrier of human genetics

Coming of age: ten years of next-generation sequencing technologies

Next-generation sequencing technologies: An overview

Next Generation Sequencing: Latent Applications in Clinical Diagnostics with the advent of Bioinformatic Frameworks

Next-generation sequencing in the clinic: Promises and challenges

Third-Generation Sequencing: The Spearhead towards the Radical Transformation of Modern Genomics

Next-Generation Sequencing and Its Application: Empowering in Public Health Beyond Reality

Next Generation Sequencing Technology in the Clinic and Its Challenges

Sequencing technologies — the next generation

State-of-the-Art Technologies to Interrogate Genetic/Genomic Components of Drug Response

Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing

Advances in Nanopore and Photoelectron-Based High-Throughput Sequencing Technology for Single-Molecule Sequencing

Targeted DNA-seq and RNA-seq of Reference Samples with Short-read and Long-read Sequencing

Next Generation Sequencing in Oncological Diagnostics: Hype or Hope?

Long read sequencing on its way to the routine diagnostics of genetic diseases

Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring

Next-Generation Sequencing (NGS): Platforms and Applications

The Application of Long-Read Sequencing to Cancer